A Possible Reprieve?

Clinical trials of an antiviral medicine named remdesivir commenced at the end of February. These trials have included 1000 patients worldwide, with 68 sites for testing. 47 of these sites are based in the United States, and 21 are based in Europe and Asia.

Preliminary data from these trials have revealed that patients with advanced lung involvement recover much faster than similar patients who have only received a placebo. However, Dr. Aneesh Mehta of Emory University (an infectious disease expert) believes that remdesivir will be more helpful for patients in earlier stages of the virus, as most antiviral medications are helpful before the climax of the sickness.

Remdesivir can only be administered intravenously, so only patients in the hospital will receive it. However, the drug will be given to as many patients as possible that qualify.

Currently, Dr. Mehta is investigating different types of medicines and therapies that could help patients further than remdesivir can alone. He believes that the method of treatment varies between patients, and he is dedicated to finding the best fit for everyone.

This is extremely exciting news for me, as I can see the light at the end of the tunnel. We still have a ways to go, but it is extremely heartwarming for me to see all of us working together to achieve a common goal. Keep hanging in there!

#medicine #cure #teens #news #blog #coronavirus #wecandoit